Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Panache Digilife Merger & Restructuring Worth ₹2.25 Cr

Panache Digilife Limited's board approved an upfront investment of up to ₹2.25 Crore in its wholly-owned subsidiary, Technofy Digital Private Limited. The strategic capital infusion will fund business expansion and capital expenditure in the IT and electronics sectors, with completion expected within six months.

Key figures
Value₹2.25 Cr
Execution periodApproximately 6 months
Source

NSE filing, NSE: PANACHE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Panache Digilife Ltd: key numbers

Share price
₹660.00
Market cap
₹1,068 Cr
Revenue (annual)
₹243.0 Cr
Net profit (annual)
₹16.18 Cr
P/E (TTM)
39.8×Sector 45.8×
Promoter holding
54.05%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Panache Digilife Ltd

All →
20:28 IST NSE
Convertible Warrants

Panache Digilife Convertible Warrants

Panache Digilife allotted 1,60,300 equity shares on conversion of preferential warrants after receiving Rs 3.16 Crore in exercise money. Paid-up capital rises to Rs 16.17 Crore.

Value
₹3.16 Cr
20:14 IST NSE
Financial Results

Panache Digilife Q2 FY27 Results: Net Profit ₹9.3 Cr, Up 564.3% YoY

Panache Digilife Ltd reported revenue from operations of ₹129.6 Cr (+231.5% YoY) and net profit of ₹9.3 Cr (+564.3% YoY) for Q2 FY27.

Key figure
Net profit ₹9.3 Cr · +564.3% YoY

Other merger & restructuring announcements

All →
19:53 IST NSE
Merger & RestructuringEmkay Global Financial Services Ltd EMKAY

Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr

Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.

Value
₹30.00 Cr
Execution
Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals